vs
Brilliant Earth Group, Inc.（BRLT）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
Brilliant Earth Group, Inc.的季度营收约是RIGEL PHARMACEUTICALS INC的1.8倍（$124.4M vs $69.8M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -2.3%，领先386.4%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 4.1%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 13.1%）
Brilliant Earth是2005年8月由贝丝·格斯坦与埃里克·格罗斯伯格创立的美国珠宝企业，总部位于加利福尼亚州旧金山，主打标注为合规溯源的钻石与其他宝石珠宝，该品牌推动了 ethical 珠宝市场的发展，2017年曾有媒体对其部分产地来源声明提出质疑。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
BRLT vs RIGL — 直观对比
营收规模更大
BRLT
是对方的1.8倍
$69.8M
营收增速更快
RIGL
高出17.1%
4.1%
净利率更高
RIGL
高出386.4%
-2.3%
两年增速更快
RIGL
近两年复合增速
13.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $124.4M | $69.8M |
| 净利润 | $-2.9M | $268.1M |
| 毛利率 | 55.9% | 91.5% |
| 营业利润率 | -0.0% | 33.2% |
| 净利率 | -2.3% | 384.0% |
| 营收同比 | 4.1% | 21.2% |
| 净利润同比 | -908.9% | 1769.2% |
| 每股收益（稀释后） | $-0.20 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BRLTRIGL
| Q4 25 | $124.4M | $69.8M | ||
| Q3 25 | $110.3M | $69.5M | ||
| Q2 25 | $108.9M | $101.7M | ||
| Q1 25 | $93.9M | $53.3M | ||
| Q4 24 | $119.5M | $57.6M | ||
| Q3 24 | $99.9M | $55.3M | ||
| Q2 24 | $105.4M | $36.8M | ||
| Q1 24 | $97.3M | $29.5M |
净利润BRLTRIGL
| Q4 25 | $-2.9M | $268.1M | ||
| Q3 25 | $-107.0K | $27.9M | ||
| Q2 25 | $-166.0K | $59.6M | ||
| Q1 25 | $-466.0K | $11.4M | ||
| Q4 24 | $358.0K | $14.3M | ||
| Q3 24 | $-141.0K | $12.4M | ||
| Q2 24 | $185.0K | $-1.0M | ||
| Q1 24 | $139.0K | $-8.2M |
毛利率BRLTRIGL
| Q4 25 | 55.9% | 91.5% | ||
| Q3 25 | 57.6% | 93.2% | ||
| Q2 25 | 58.3% | 95.6% | ||
| Q1 25 | 58.6% | 91.7% | ||
| Q4 24 | 59.6% | 89.9% | ||
| Q3 24 | 60.8% | 85.5% | ||
| Q2 24 | 60.8% | 92.4% | ||
| Q1 24 | 59.9% | 93.1% |
营业利润率BRLTRIGL
| Q4 25 | -0.0% | 33.2% | ||
| Q3 25 | -0.6% | 40.9% | ||
| Q2 25 | -1.1% | 60.1% | ||
| Q1 25 | -3.8% | 23.9% | ||
| Q4 24 | 2.0% | 28.9% | ||
| Q3 24 | -1.1% | 25.4% | ||
| Q2 24 | 1.1% | 1.2% | ||
| Q1 24 | 0.9% | -23.6% |
净利率BRLTRIGL
| Q4 25 | -2.3% | 384.0% | ||
| Q3 25 | -0.1% | 40.2% | ||
| Q2 25 | -0.2% | 58.6% | ||
| Q1 25 | -0.5% | 21.5% | ||
| Q4 24 | 0.3% | 24.9% | ||
| Q3 24 | -0.1% | 22.5% | ||
| Q2 24 | 0.2% | -2.8% | ||
| Q1 24 | 0.1% | -27.9% |
每股收益（稀释后）BRLTRIGL
| Q4 25 | $-0.20 | $14.11 | ||
| Q3 25 | $-0.01 | $1.46 | ||
| Q2 25 | $-0.01 | $3.28 | ||
| Q1 25 | $-0.03 | $0.63 | ||
| Q4 24 | $0.02 | $0.82 | ||
| Q3 24 | $-0.01 | $0.70 | ||
| Q2 24 | $0.01 | $-0.06 | ||
| Q1 24 | $0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $79.1M | $155.0M |
| 总债务越低越好 | $0 | $52.5M |
| 股东权益账面价值 | $12.3M | $391.5M |
| 总资产 | $200.9M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.00× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资BRLTRIGL
| Q4 25 | $79.1M | $155.0M | ||
| Q3 25 | $73.4M | $137.1M | ||
| Q2 25 | $133.6M | $108.4M | ||
| Q1 25 | $147.3M | $77.1M | ||
| Q4 24 | $161.9M | $77.3M | ||
| Q3 24 | $152.7M | $61.1M | ||
| Q2 24 | $152.2M | $49.1M | ||
| Q1 24 | $147.5M | $49.5M |
总债务BRLTRIGL
| Q4 25 | $0 | $52.5M | ||
| Q3 25 | $0 | $60.0M | ||
| Q2 25 | $34.5M | $60.0M | ||
| Q1 25 | $54.5M | $60.0M | ||
| Q4 24 | $55.7M | $60.0M | ||
| Q3 24 | $58.1M | $60.0M | ||
| Q2 24 | $58.0M | $60.0M | ||
| Q1 24 | $58.8M | $60.0M |
股东权益BRLTRIGL
| Q4 25 | $12.3M | $391.5M | ||
| Q3 25 | $12.0M | $117.6M | ||
| Q2 25 | $15.3M | $81.9M | ||
| Q1 25 | $14.9M | $18.6M | ||
| Q4 24 | $15.3M | $3.3M | ||
| Q3 24 | $14.5M | $-14.6M | ||
| Q2 24 | $14.1M | $-29.9M | ||
| Q1 24 | $13.3M | $-31.7M |
总资产BRLTRIGL
| Q4 25 | $200.9M | $513.6M | ||
| Q3 25 | $203.0M | $242.5M | ||
| Q2 25 | $260.9M | $206.7M | ||
| Q1 25 | $269.6M | $176.0M | ||
| Q4 24 | $281.2M | $164.0M | ||
| Q3 24 | $273.2M | $139.4M | ||
| Q2 24 | $272.5M | $128.4M | ||
| Q1 24 | $268.2M | $126.5M |
负债/权益比BRLTRIGL
| Q4 25 | 0.00× | 0.13× | ||
| Q3 25 | 0.00× | 0.51× | ||
| Q2 25 | 2.26× | 0.73× | ||
| Q1 25 | 3.65× | 3.23× | ||
| Q4 24 | 3.63× | 18.25× | ||
| Q3 24 | 4.01× | — | ||
| Q2 24 | 4.13× | — | ||
| Q1 24 | 4.43× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $7.2M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $5.7M | — |
| 自由现金流率自由现金流/营收 | 4.6% | — |
| 资本支出强度资本支出/营收 | 1.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $5.8M | — |
8季度趋势，按日历期对齐
经营现金流BRLTRIGL
| Q4 25 | $7.2M | $22.0M | ||
| Q3 25 | $608.0K | $24.0M | ||
| Q2 25 | $9.1M | $30.5M | ||
| Q1 25 | $-7.1M | $-893.0K | ||
| Q4 24 | $14.1M | $14.5M | ||
| Q3 24 | $2.0M | $21.7M | ||
| Q2 24 | $7.3M | $302.0K | ||
| Q1 24 | $-5.8M | $-5.0M |
自由现金流BRLTRIGL
| Q4 25 | $5.7M | — | ||
| Q3 25 | $-3.0K | — | ||
| Q2 25 | $7.9M | — | ||
| Q1 25 | $-7.9M | — | ||
| Q4 24 | $11.9M | — | ||
| Q3 24 | $674.0K | — | ||
| Q2 24 | $6.5M | — | ||
| Q1 24 | $-6.4M | — |
自由现金流率BRLTRIGL
| Q4 25 | 4.6% | — | ||
| Q3 25 | -0.0% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | -8.4% | — | ||
| Q4 24 | 10.0% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 6.1% | — | ||
| Q1 24 | -6.5% | — |
资本支出强度BRLTRIGL
| Q4 25 | 1.2% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | 1.1% | — | ||
| Q1 25 | 0.8% | — | ||
| Q4 24 | 1.8% | — | ||
| Q3 24 | 1.3% | — | ||
| Q2 24 | 0.8% | — | ||
| Q1 24 | 0.6% | — |
现金转化率BRLTRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 39.36× | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | 39.51× | — | ||
| Q1 24 | -41.65× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BRLT
| US | $120.3M | 97% |
| Non Us | $4.2M | 3% |
RIGL
暂无分部数据
